These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 10686688)

  • 21. Venous thrombosis prophylaxis with low-molecular-weight heparin in hip and knee arthroplasty.
    Colwell CW
    Instr Course Lect; 2002; 51():487-9. PubMed ID: 12064138
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithrombotics and anticoagulants in coronary syndromes and stroke.
    Turpie AG
    Semin Thromb Hemost; 2000; 26 Suppl 1():79-83. PubMed ID: 11011811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous coronary intervention or thrombolytics in ST-elevation infarction. What is the emperor really wearing?
    Dellborg M
    Scand Cardiovasc J; 2002 Aug; 36(4):197-200. PubMed ID: 12201965
    [No Abstract]   [Full Text] [Related]  

  • 24. Current status of low molecular weight heparins in clinical practice.
    Vidhya MR; Sathyamurthy I
    J Assoc Physicians India; 2000 Feb; 48(2):216-20. PubMed ID: 11229152
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombotic and antiplatelet therapies in relation to risk stratification in patients with non-ST elevation acute coronary syndrome: insights from the Sino-Global Registry of Acute Coronary Events.
    Zhang LJ; Chen YD; Song XT; Zhao FH; Lü SZ
    Chin Med J (Engl); 2009 Mar; 122(5):502-8. PubMed ID: 19323898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
    Wong GC; Giugliano RP
    Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty.
    Colwell CW; Hardwick ME
    Clin Orthop Relat Res; 2006 Nov; 452():181-5. PubMed ID: 17016231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'STAR' war against coronary thrombosis.
    Gambhir DS; Gambhir J
    Indian Heart J; 1995; 47(5):459-60. PubMed ID: 8714497
    [No Abstract]   [Full Text] [Related]  

  • 29. Thromboembolic diseases.
    Wakefield TW; Caprini J; Comerota AJ
    Curr Probl Surg; 2008 Dec; 45(12):844-99. PubMed ID: 18984095
    [No Abstract]   [Full Text] [Related]  

  • 30. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 31. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombolytic treatment of type A right atrial thrombi].
    Greco F
    G Ital Cardiol; 1999 Aug; 29(8):937-8. PubMed ID: 10488457
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial salvage--a perspective.
    Gordon GD; Commerford PJ
    S Afr Med J; 1988 May; 73(9):509-10. PubMed ID: 3375935
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful and unsuccessful coronary thrombolysis.
    Davies MJ
    Br Heart J; 1989 May; 61(5):381-4. PubMed ID: 2660892
    [No Abstract]   [Full Text] [Related]  

  • 35. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).
    Budaj A; Brieger D; Steg PG; Goodman SG; Dabbous OH; Fox KA; Avezum A; Cannon CP; Mazurek T; Flather MD; Van De Werf F;
    Am Heart J; 2003 Dec; 146(6):999-1006. PubMed ID: 14660991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Non-fractionated heparin versus low molecular weight heparin in acute coronary syndromes].
    González Pacheco H
    Arch Cardiol Mex; 2001; 71 Suppl 1():S63-8. PubMed ID: 11565348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of anti-thrombins and low molecular weight heparins for acute coronary syndromes.
    Cohen M
    J Invasive Cardiol; 1999 Jun; 11 Suppl A():2A-6A. PubMed ID: 10745604
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-molecular-weight heparins and glycoprotein IIb/IIIa inhibitors with percutaneous coronary intervention in acute coronary syndromes.
    Shimpi RA
    J Invasive Cardiol; 2003 Aug; 15(8):460-5. PubMed ID: 12890880
    [No Abstract]   [Full Text] [Related]  

  • 39. [Management of acute coronary syndrome. New pharmacologic approaches].
    Galvani M; Nicolini FA; Ferrini D; Ottani F
    G Ital Cardiol; 1999; 29 Suppl 4():23-7. PubMed ID: 10686688
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.